Abridge CAIHL draft report

Abridge: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Abridge is clinician-controlled documentation and decision support. UChicago Medicine documents patient refusal and note-correction routes, but these local commitments cannot describe every customer. Platform expansion does not establish that all patient recordings feed every offering.

Scope and agency posture

Enterprise documentation and clinical decision support. UChicago Medicine is one documented deployment example, not evidence of uniform practice across all customers.

Posture: Mixed.

Axis: 43/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

• UChicago states clinicians obtain consent, declining does not change care, patients can review notes and request corrections by message, and audio is deleted within one week. These are local published commitments. https://www.uchicagomedicine.org/forefront/patient-care/ai-ambient-clinical-documentation-what-to-know

• Abridge's CDS page gives clinicians control over information, notes and actions. It promises links to EHR facts and evidence sources and says PHI stays within its architecture and is not used for training. Those CDS-specific claims do not establish every customer's downstream data use. https://www.abridge.com/cds

Patient authority

Inference from the documented workflow: Clinical users decide what enters the record and what action follows. UChicago documents a real patient refusal and correction route, with no claim that the patient controls the assistant itself.

Critical capacity

Editorial assessment: Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.

Informed control

Editorial assessment: Consent and retention must be described by deployment. Vendor expansion into payer and life-sciences workflows does not prove that the same patient audio feeds every offering.

Assessment and limits

Mixed remains defensible for indirect benefits and locally documented choice. The baseline overgeneralizes platform expansion into a universal audio-use claim. Historical lawsuit allegations should retain dates and must not be presented as current adjudicated facts.

Confidence: Moderate for public deployment policy and CDS design.

Remaining uncertainty: Actual consent practice and downstream use across customers, and current litigation status, were not established

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

• Reviewer/model: OpenAI Codex / GPT-6.
• Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
• Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
• Earlier review: 2026-06-12. Historical assessment. Earlier claims are not automatically reverified by this publication.